Literature DB >> 18165405

Surgical and behavioral treatments for vestibulodynia: two-and-one-half year follow-up and predictors of outcome.

Sophie Bergeron1, Samir Khalifé, Howard I Glazer, Yitzchak M Binik.   

Abstract

OBJECTIVE: To estimate whether treatment gains for provoked vestibulodynia participants randomly assigned to vestibulectomy, biofeedback, and cognitive-behavioral therapy in a previous study would be maintained from the last assessment-a 6-month follow-up-to the present 2.5-year follow-up. Although all three treatments yielded significant improvements at 6-month follow-up, vestibulectomy resulted in approximately twice the pain reduction as compared with the two other treatments. A second goal of the present study was to identify predictors of outcome.
METHODS: In a university hospital, 51 of the 78 women from the original study were reassessed 2.5 years after the end of their treatment. They completed 1) a gynecologic examination involving the cotton-swab test, 2) a structured interview, and 3) validated pain and sexual functioning measures.
RESULTS: Results from the multivariate analysis of variance conducted on the pain measures showed a significant time main effect (P<.05) and a significant treatment main effect (P<.01), indicating that participants had less pain at the 2.5-year follow-up than at the previous 6-month follow-up. Results from the multivariate analysis of variance conducted on sexual functioning measures showed that participants remained unchanged between the 6-month and 2.5-year follow-up and that there were no group differences. Higher pretreatment pain intensity predicted poorer outcomes at the 2.5-year follow-up for vestibulectomy (P<.01), biofeedback (P<.05), and cognitive-behavioral therapy (P<.01). Erotophobia also predicted a poorer outcome for vestibulectomy (P<.001).
CONCLUSION: Treatment gains were maintained at the 2.5-year follow-up. Outcome was predicted by pretreatment pain and psychosexual factors. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2008        PMID: 18165405     DOI: 10.1097/01.AOG.0000295864.76032.a7

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  15 in total

1.  Early experience with topical meloxicam and lidocaine combination for the treatment of vulvodynia.

Authors:  Rufina Kim; Kerri-Lynn Kelly; Merle Olson; J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2018-04-06       Impact factor: 1.862

Review 2.  A psychosocial approach to female genital pain.

Authors:  Marieke Dewitte; Charmaine Borg; Lior Lowenstein
Journal:  Nat Rev Urol       Date:  2017-11-28       Impact factor: 14.432

Review 3.  Biofeedback for the treatment of female pelvic floor muscle dysfunction: a systematic review and meta-analysis.

Authors:  Fátima Faní Fitz; Ana Paula Magalhães Resende; Liliana Stüpp; Marair Gracio Ferreira Sartori; Manoel João Batista Castello Girão; Rodrigo Aquino Castro
Journal:  Int Urogynecol J       Date:  2012-03-17       Impact factor: 2.894

Review 4.  Treatment of Vulvodynia: Pharmacological and Non-Pharmacological Approaches.

Authors:  Natalie O Rosen; Samantha J Dawson; Melissa Brooks; Susan Kellogg-Spadt
Journal:  Drugs       Date:  2019-04       Impact factor: 9.546

Review 5.  Pain after suburethral sling insertion for urinary stress incontinence.

Authors:  Jonathan Duckett; Andrew Baranowski
Journal:  Int Urogynecol J       Date:  2012-07-03       Impact factor: 2.894

6.  Self-management, amitriptyline, and amitripyline plus triamcinolone in the management of vulvodynia.

Authors:  Candace S Brown; Jim Wan; Gloria Bachmann; Ray Rosen
Journal:  J Womens Health (Larchmt)       Date:  2009-02       Impact factor: 2.681

7.  A randomized clinical trial for women with vulvodynia: Cognitive-behavioral therapy vs. supportive psychotherapy.

Authors:  Robin M Masheb; Robert D Kerns; Christine Lozano; Mary Jane Minkin; Susan Richman
Journal:  Pain       Date:  2008-11-20       Impact factor: 6.961

Review 8.  Vulvodynia.

Authors:  Sophie Bergeron; Barbara D Reed; Ursula Wesselmann; Nina Bohm-Starke
Journal:  Nat Rev Dis Primers       Date:  2020-04-30       Impact factor: 52.329

9.  'ReConnect': a model for working with persistent pain patients on improving sexual relationships.

Authors:  Sarah Edwards; Anna Mandeville; Katrine Petersen; Julia Cambitzi; Amanda C de C Williams; Katherine Herron
Journal:  Br J Pain       Date:  2019-06-10

Review 10.  Etiology, diagnosis, and clinical management of vulvodynia.

Authors:  Leslie A Sadownik
Journal:  Int J Womens Health       Date:  2014-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.